{"id":"https://openalex.org/W4403721737","doi":"https://doi.org/10.14309/01.ajg.0001036676.42521.e3","title":"S1827 Elafibranor for the Treatment of Primary Biliary Cholangitis: Study Designs of the ELFIDENCE, ELSPIRE, and ELFINITY Phase III/IV Trials","display_name":"S1827 Elafibranor for the Treatment of Primary Biliary Cholangitis: Study Designs of the ELFIDENCE, ELSPIRE, and ELFINITY Phase III/IV Trials","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403721737","doi":"https://doi.org/10.14309/01.ajg.0001036676.42521.e3"},"language":"en","primary_location":{"id":"doi:10.14309/01.ajg.0001036676.42521.e3","doi":"https://doi.org/10.14309/01.ajg.0001036676.42521.e3","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0001036676.42521.e3","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017083142","display_name":"Marcelo Kugelmas","orcid":"https://orcid.org/0009-0004-3978-9720","observed_orcids":["https://orcid.org/0009-0004-3978-9720","https://orcid.org/0000-0002-4396-813X"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Marcelo Kugelmas","raw_affiliation_strings":["South Denver Gastroenterology, Englewood, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Denver Gastroenterology, Englewood, CO;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091028785","display_name":"Kris V. Kowdley","orcid":"https://orcid.org/0000-0002-8553-3652","observed_orcids":["https://orcid.org/0000-0002-8553-3652"]},"institutions":[{"id":"https://openalex.org/I4210119989","display_name":"Liver Institute Northwest","ror":"https://ror.org/02jrddb23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210119989"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kris V. Kowdley","raw_affiliation_strings":["Liver Institute Northwest, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liver Institute Northwest, Seattle, WA;","institution_ids":["https://openalex.org/I4210119989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038613197","display_name":"Christina Hanson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina Hanson","raw_affiliation_strings":["South Denver Gastroenterology, Englewood, CO;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Denver Gastroenterology, Englewood, CO;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086284606","display_name":"Mordechai Rabinovitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mordechai Rabinovitz","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, PA;","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053057630","display_name":"Marwan Sleiman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183367347","display_name":"Ipsen (France)","ror":"https://ror.org/00d801g55","country_code":"FR","type":"company","lineage":["https://openalex.org/I183367347"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marwan Sleiman","raw_affiliation_strings":["Ipsen, Boulogne-Billancourt, Ile-de-France, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipsen, Boulogne-Billancourt, Ile-de-France, France;","institution_ids":["https://openalex.org/I183367347"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard Allan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093143","display_name":"Ipsen (United Kingdom)","ror":"https://ror.org/00gmnqd91","country_code":"GB","type":"company","lineage":["https://openalex.org/I183367347","https://openalex.org/I4210093143"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard Allan","raw_affiliation_strings":["Ipsen, London, England, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipsen, London, England, United Kingdom;","institution_ids":["https://openalex.org/I4210093143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067924430","display_name":"Katerine Boutros","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katerine Boutros","raw_affiliation_strings":["Ipsen, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipsen, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036390483","display_name":"Ana Bozas","orcid":"https://orcid.org/0000-0003-4231-1774","observed_orcids":["https://orcid.org/0000-0003-4231-1774"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ana Bozas","raw_affiliation_strings":["Ipsen, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipsen, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089253455","display_name":"Christelle Pommie","orcid":"https://orcid.org/0009-0001-8771-2304","observed_orcids":["https://orcid.org/0009-0001-8771-2304"]},"institutions":[{"id":"https://openalex.org/I183367347","display_name":"Ipsen (France)","ror":"https://ror.org/00d801g55","country_code":"FR","type":"company","lineage":["https://openalex.org/I183367347"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christelle Pommie","raw_affiliation_strings":["Ipsen, Boulogne-Billancourt, Ile-de-France, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipsen, Boulogne-Billancourt, Ile-de-France, France;","institution_ids":["https://openalex.org/I183367347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111489424","display_name":"Jianfen Shu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jianfen Shu","raw_affiliation_strings":["Ipsen, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipsen, Cambridge, MA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083890529","display_name":"Nuno Antunes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nuno Antunes","raw_affiliation_strings":["Ipsen, Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipsen, Cambridge, MA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090959657","display_name":"J\u00f6rn Markus Schattenberg","orcid":"https://orcid.org/0000-0002-4224-4703","observed_orcids":["https://orcid.org/0000-0002-4224-4703"]},"institutions":[{"id":"https://openalex.org/I91712215","display_name":"Saarland University","ror":"https://ror.org/01jdpyv68","country_code":"DE","type":"education","lineage":["https://openalex.org/I91712215"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"J\u00f6rn M. Schattenberg","raw_affiliation_strings":["Saarland University Medical Center, Homburg, Saarland, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Saarland University Medical Center, Homburg, Saarland, Germany","institution_ids":["https://openalex.org/I91712215"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5017083142"],"corresponding_institution_ids":[],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"119","issue":"10S","first_page":"S1317","last_page":"S1318"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11834","display_name":"Liver Diseases and Immunity","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12460","display_name":"Pediatric Hepatobiliary Diseases and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/elafibranor","display_name":"elafibranor","score":0.9160000085830688},{"id":"https://openalex.org/keywords/primary-biliary-cholangitis","display_name":"primary biliary cirrhosis","score":1.0},{"id":"https://openalex.org/keywords/compensated-cirrhosis","display_name":"compensated cirrhosis","score":0.8610000014305115},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.7229999899864197},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.5709999799728394},{"id":"https://openalex.org/keywords/cholestasis","display_name":"cholestasis","score":0.6019999980926514},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.828000009059906},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.3930000066757202},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4869999885559082},{"id":"https://openalex.org/keywords/alkaline-phosphatase","display_name":"alkaline phosphatase","score":0.718999981880188},{"id":"https://openalex.org/keywords/non-interventional-study","display_name":"non-interventional study","score":0.5260000228881836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9656362533569336},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.574652373790741},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5378545522689819},{"id":"https://openalex.org/C2775982439","wikidata":"https://www.wikidata.org/wiki/Q3562150","display_name":"Biliary tract","level":2,"score":0.5110365152359009}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14309/01.ajg.0001036676.42521.e3","doi":"https://doi.org/10.14309/01.ajg.0001036676.42521.e3","is_oa":false,"landing_page_url":"https://doi.org/10.14309/01.ajg.0001036676.42521.e3","pdf_url":null,"source":{"id":"https://openalex.org/S66441642","display_name":"The American Journal of Gastroenterology","issn_l":"0002-9270","issn":["0002-9270","1572-0241"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Gastroenterology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4403391574","https://openalex.org/W4414963972","https://openalex.org/W4388621682","https://openalex.org/W4414039699","https://openalex.org/W4403058223","https://openalex.org/W4414963709","https://openalex.org/W4403391636","https://openalex.org/W3125174675","https://openalex.org/W7221170111","https://openalex.org/W4406721598"],"abstract_inverted_index":{"Introduction:":[0],"Primary":[1,103,365,375,690,867],"biliary":[2,353],"cholangitis":[3],"(PBC)":[4],"is":[5,1074],"a":[6,27,145,225,462,654,828],"rare":[7],"autoimmune":[8],"cholestatic":[9],"liver":[10,24,397,406,919,1004],"disease":[11,407],"characterized":[12],"by":[13,952],"the":[14,49,60,73,80,114,181,262,298,309,316,384,391,622,904,1065,1072],"destruction":[15],"of":[16,37,59,77,82,124,148,157,185,204,235,237,267,297,308,313,318,349,383,394,412,429,439,452,470,537,541,585,607,615,621,648,651,697,701,717,721,742,746,769,783,792,815,874,892,896,903,962,990,1012,1021,1038,1087],"interlobular":[17],"bile":[18],"ducts,":[19],"leading":[20],"to":[21,70,137,179,218,260,381,390,427,551,583,625,646,709,726,819,839,878,907,966,983],"cholestasis":[22,38],"and":[23,65,75,91,104,130,142,161,170,183,191,207,240,249,265,285,301,311,328,334,347,366,422,436,446,454,480,491,502,515,529,544,578,714,738,749,785,794,889,959,998,1017,1033,1092],"fibrosis.":[25],"Elafibranor,":[26],"peroxisome":[28],"proliferator-activated":[29],"receptor":[30],"(PPAR)-\u03b1/\u03b4":[31],"agonist,":[32],"significantly":[33],"improved":[34],"prognostic":[35],"biomarkers":[36],"at":[39,562,822,1076],"Week":[40,694,710,727,762,803,840,859],"(Wk)":[41],"52":[42,695,732,767,804,843,862],"in":[43,48,79,99,113,126,167,187,246,269,275,315,331,351,402,434,457,549,555,567,618,633,736,758,808,832,900,918,975,1003,1044],"participants":[44,440,556,608,652,698,718,743,770,816,875,893,963,1013,1022,1039],"(patients)":[45],"with":[46,128,189,271,320,557,653,699,719,817,827,876,894,964,1023],"PBC":[47,129,190,272,592,599,657,662,681,809,833,979],"phase":[50,119,175,256],"III":[51,120],"ELATIVE":[52],"trial":[53,110,123,178],"(NCT04526665).1":[54],"Here,":[55],"we":[56],"describe":[57],"methodologies":[58],"ELFIDENCE":[61,373],"(NCT06016842),":[62],"ELSPIRE":[63,688],"(NCT06383403),":[64],"ELFINITY":[66,302,865],"(NCT06447168)":[67,866],"trials":[68,303],"designed":[69],"further":[71,306],"evaluate":[72,180,329],"safety":[74,184,312,348],"efficacy":[76,106,182,310,368,376,416,691,705,868,881],"elafibranor":[78,125,138,186,268,280,314,330,350],"treatment":[81,227,274,317,950,984],"PBC,":[83,321],"including":[84],"assessing":[85],"complementary":[86],"populations":[87],"not":[88],"yet":[89],"analyzed,":[90],"providing":[92],"data":[93,323],"on":[94,212,465,596,603,933,938,949,978,987],"long-term":[95,122],"clinical":[96,1060],"outcomes":[97],"and/or":[98],"real-world":[100,276,332],"settings.":[101,277],"Methods:":[102],"secondary":[105,367],"endpoints":[107,154,232,369,417,706,882],"for":[108,291,324,404,969,1068],"each":[109],"are":[111,289],"presented":[112],"Table":[115,362],"1.":[116,337,363],"ELFIDENCE:":[117],"A":[118,174,253],"randomized,":[121],"patients":[127,188,270,319],"compensated":[131],"cirrhosis.":[132],"Pts":[133,220,278],"will":[134,221,304],"be":[135,222],"randomized":[136,177],"(80mg)":[139],"or":[140,216,399,410,1056,1063,1071,1081],"placebo":[141],"assessed":[143,223],"over":[144,224],"maximum":[146],"duration":[147],"42":[149,1054],"months":[150,425,581,644,971],"(target":[151,229,293],"enrollment=276).":[152],"Safety":[153,231],"include":[155,233],"assessment":[156,234],"adverse":[158],"events":[159],"(AEs)":[160],"clinically":[162,241,829,1024,1041],"significant":[163,242,1025,1042],"changes":[164,243,1026,1043],"from":[165,244,388,432,565,588,631,667,734,752,756,806,845,916,926,973,1001],"baseline":[166,245,433,563,566,589,632,668,708,725,735,757,801,807,823,838,846,917,927,974,1002,1007],"laboratory":[168,247,1028],"tests":[169,248],"vital":[171,250,1045],"signs.":[172,251],"ELSPIRE:":[173],"IIIb":[176],"an":[192,1058,1077],"incomplete":[193],"response":[194,463,655,831,877,965],"(defined":[195],"as":[196,281,943,1048,1084,1095],"alkaline":[197],"phosphatase":[198],"[ALP]":[199],">1":[200],"\u00d7":[201,210,444,475,486,497,508,513,523,527,553,560,775,780,789],"upper":[202],"limit":[203],"normal":[205,1085],"[ULN]":[206],"<":[208,473,484,495,506,511,773,778,787],"1.67":[209,496],"ULN)":[211],"(ursodeoxycholic":[213],"acid)":[214],"UDCA":[215],"intolerance":[217],"UDCA.":[219],"52-wk":[226],"period":[228],"enrollment=72).":[230],"AEs":[236],"varying":[238],"severity":[239],"ELFINITY:":[252],"prospective":[254],"non-interventional,":[255],"IV":[257],"multicenter":[258],"study":[259,1066,1073],"assess":[261],"effectiveness,":[263],"safety,":[264],"tolerability":[266],"receiving":[273],"prescribed":[279],"per":[282],"approved":[283],"label":[284],"health":[286],"professional":[287],"decision":[288],"eligible":[290],"inclusion":[292],"enrollment=424).":[294],"Conclusion:":[295],"Results":[296],"ELFIDENCE,":[299],"ELSPIRE,":[300],"facilitate":[305],"evaluation":[307],"provide":[322],"additional":[325],"patient":[326],"populations,":[327],"settings":[333],"long-term.":[335],"Reference:":[336],"Kowdley":[338],"KV,":[339],"Bowlus":[340],"CL,":[341],"Levy":[342],"C,":[343],"et":[344],"al.":[345],"Efficacy":[346],"primary":[352],"cholangitis.":[354],"N":[355],"Engl":[356],"J":[357],"Med.":[358],"2024":[359],"Feb":[360],"29;390(9):795-805.":[361],"-":[364],"Study":[370],"Timeframe":[371],"Outcome":[372],"(NCT06016842)":[374],"endpoint":[377,692,869],"From":[378,707,724,800,837,1006],"randomization":[379,389],"up":[380,426,582,645],"end":[382,428,584,647],"study1":[385],"Event-free":[386],"survival":[387],"first":[392],"occurrence":[393],"all-cause":[395],"mortality,":[396],"transplant":[398],"decompensation,":[400],"change":[401],"model":[403],"end-stage":[405],"3.0":[408],"score,":[409],"development":[411],"hepatocellular":[413],"carcinoma":[414],"Secondary":[415,704,880],"At":[418,575,693,761,858,870,883,954,995],"Month":[419,576,871,884,955,996,1009,1053],"6,":[420,886],"12":[421,424,577,580,997],"every":[423,579,993],"treatment1":[430,586,649],"Change":[431,564,587,617,630,666,733,805,844,899,915,925,972,1000],"ALP":[435,442,468,472,477,483,488,494,499,505,521,640,702,722,737,747,759,772,784,795,897],"TB":[437,453,458,481,492,503,516,530,543,550,558,739,777,786,793,1096],"Percentage":[438,606,650,696,716,741,768,814,873,891,961,1011,1020,1037],"with:":[441,609,744,771],"\u22641.67":[443],"ULN":[445,514,528,554,561],"TB\u2264ULN;":[447],"complete":[448,797,1052],"biochemical":[449,798],"response;2":[450],"normalization":[451,536,540,700,720,745,782,791,895],"ALP;3":[455],"stabilization":[456],"(i.e.":[459,824],"no":[460,613],"increase);4":[461],"based":[464,595,602,932,937,977,986],"albumin":[466,545,629,914],"normalization;":[467],"reduction":[469,548],"40%;":[471],"1.5":[474,485],"ULN,":[476,487,498,509,524],"decrease":[478,489,500,751,755],"\u226515%":[479,501,750],"\u2264ULN;":[482,493,504],"\u226540%":[490,754],"3":[507],"AST":[510,525],"2":[512],"\u22641":[517,531],"mg/dL":[518,532],"(Paris":[519,533],"I);":[520],"\u22641.5":[522,526],"II":[534],"criteria);":[535,547],"abnormal":[538,542],"TB;":[539,912],"(Rotterdam":[546],"\u22640.6":[552],">0.6":[559],"lipid":[568],"parameters:":[569,921],"TC;":[570],"HDL-C;":[571],"VLDL-C;":[572],"LDL-C;":[573],"TG":[574],"in:":[590,656,669,847,928,1027],"LSM;":[591],"risk":[593,600],"scores":[594,601,864],"GLOBE":[597],"score;":[598,680,685],"UK-PBC":[604],"score":[605,813,825,981],"LSM":[610,616],"\u226515":[611],"kPa;":[612],"worsening":[614],"serum":[619,901],"levels":[620,703,723,740,748,760,898,902,1086],"following":[623,905],"compared":[624,906],"baseline:":[626,908],"ALT;":[627,909],"GGT;":[628,911],"hepatic":[634],"function:":[635],"conjugated":[636,922],"bilirubin;":[637],"INR;":[638,1093],"fractionated":[639],"Assessed":[641],"through":[642,802,1008],"6":[643,872],"Worst":[658,663,682,810,834],"Itch":[659,664,683,811,835],"NRS":[660,684,812],"score;5":[661],"NRS6":[665],"5D-Itch":[670],"scale;":[671],"PGI-S;":[672,850],"PROMIS":[673,853],"Fatigue":[674,854],"Short":[675,855],"Form":[676,856],"7a;":[677],"ESS;":[678],"PBC-40":[679,851,934],"EQ-5D-5L;":[686],"WPAI-GH":[687],"(NCT06383403)":[689],"4,":[711,728,763,841,860],"12,":[712,729,764,887,957],"24,":[713,730,765,842,861],"36":[715],"36,":[731,766],"baseline;":[753],"0.5":[774],"ULN;":[776,781,790],"0.7":[779,788],"Levels;":[796],"response2":[799],"moderate":[818],"severe":[820],"pruritus":[821,945,976],"\u22654)":[826],"meaningful":[830],"NRS7":[836],"5-D":[848,939,944],"itch;":[849],"QoL;":[852],"7a":[857],"PGI-C":[863],"treatment8":[879,967],"3,":[885,956],"18,":[888,958],"24":[890,960,970,999,1010],"AST;":[910],"creatinine;":[913],"function":[920],"(direct)":[923],"bilirubin":[924],"FACIT-Fatigue;":[929],"PSQI;":[930],"QoL":[931,936],"questionnaire;":[935],"itch":[940,980],"(also":[941],"known":[942],"scale)":[946],"Participant\u2019s":[947],"satisfaction":[948],"measured":[951,985],"TSQM":[953],"Monthly":[968],"Adherence":[982],"participant":[988],"report":[989],"missed":[991],"doses":[992],"month":[994],"stiffness9":[1005],"experiencing":[1014],"AEs,":[1015],"AESIs,":[1016],"special":[1018],"situations":[1019],"parameters":[1029],"(blood":[1030],"chemistry,":[1031],"hematology,":[1032],"coagulation);":[1034],"physical":[1035],"examination10":[1036],"developing":[1040],"signs10":[1046],"[1]Defined":[1047],"whichever":[1049],"comes":[1050],"first:":[1051],"visit,":[1055],"experience":[1057],"adjudicated":[1059],"outcome":[1061],"event,":[1062],"discontinue":[1064],"prematurely":[1067],"any":[1069],"reason,":[1070],"completed":[1075],"analysis":[1078],"timepoint":[1079],"(interim":[1080],"final);":[1082],"[2]Defined":[1083],"TB,":[1088],"ALP,":[1089],"aminotransferases,":[1090],"albumin,":[1091],"[3]Defined":[1094]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2024-10-25T00:00:00"}